Amy M Knight1, Joyce Maygers2, Kimberly A Foltz3, Isha S John4, Hsin Chieh Yeh5,6, Daniel J Brotman6. 1. Division of Hospital Medicine, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States. 2. Department of Care Management, Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States. 3. Division of Clinical Informatics, Department of Information Services, Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States. 4. American Pharmacists Association, Washington, District of Columbia, United States. 5. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States. 6. Division of General Internal Medicine, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States.
Abstract
OBJECTIVE: This study aimed to determine the effects of reducing the number of drug-drug interaction (DDI) alerts in an order entry system. METHODS: Retrospective pre-post analysis at an urban medical center of the rates of medication alerts and alert acceptance during a 5-month period before and 5-month period after the threshold for firing DDI alerts was changed from "intermediate" to "severe." To ensure that we could determine varying response to each alert type, we took an in-depth look at orders generating single alerts. RESULTS: Before the intervention, 241,915 medication orders were placed, of which 25.6% generated one or more medication alerts; 5.3% of the alerts were accepted. During the postintervention period, 245,757 medication orders were placed of which 16.0% generated one or more medication alerts, a 37.5% relative decrease in alert rate (95% confidence interval [CI]: -38.4 to -36.8%), but only a 9.6% absolute decrease (95% CI: -9.4 to -9.9%). 7.4% of orders generating alerts were accepted postintervention, a 39.6% relative increase in acceptance rate (95% CI: 33.2-47.2%), but only a 2.1% absolute increase (95% CI: 1.8-2.4%). When only orders generating a single medication alert were considered, there was a 69.1% relative decrease in the number of orders generating DDI alerts, and an 85.7% relative increase in the acceptance rate (95% CI: 58.6-126.2%), though only a 1.8% absolute increase (95% CI: 1.3-2.3%). CONCLUSION: Eliminating intermediate severity DDI alerts resulted in a statistically significant decrease in alert burden and increase in the rate of medication alert acceptance, but alert acceptance remained low overall. Georg Thieme Verlag KG Stuttgart · New York.
OBJECTIVE: This study aimed to determine the effects of reducing the number of drug-drug interaction (DDI) alerts in an order entry system. METHODS: Retrospective pre-post analysis at an urban medical center of the rates of medication alerts and alert acceptance during a 5-month period before and 5-month period after the threshold for firing DDI alerts was changed from "intermediate" to "severe." To ensure that we could determine varying response to each alert type, we took an in-depth look at orders generating single alerts. RESULTS: Before the intervention, 241,915 medication orders were placed, of which 25.6% generated one or more medication alerts; 5.3% of the alerts were accepted. During the postintervention period, 245,757 medication orders were placed of which 16.0% generated one or more medication alerts, a 37.5% relative decrease in alert rate (95% confidence interval [CI]: -38.4 to -36.8%), but only a 9.6% absolute decrease (95% CI: -9.4 to -9.9%). 7.4% of orders generating alerts were accepted postintervention, a 39.6% relative increase in acceptance rate (95% CI: 33.2-47.2%), but only a 2.1% absolute increase (95% CI: 1.8-2.4%). When only orders generating a single medication alert were considered, there was a 69.1% relative decrease in the number of orders generating DDI alerts, and an 85.7% relative increase in the acceptance rate (95% CI: 58.6-126.2%), though only a 1.8% absolute increase (95% CI: 1.3-2.3%). CONCLUSION: Eliminating intermediate severity DDI alerts resulted in a statistically significant decrease in alert burden and increase in the rate of medication alert acceptance, but alert acceptance remained low overall. Georg Thieme Verlag KG Stuttgart · New York.
Authors: Aaron S Kesselheim; Kathrin Cresswell; Shobha Phansalkar; David W Bates; Aziz Sheikh Journal: Health Aff (Millwood) Date: 2011-12 Impact factor: 6.301
Authors: Shobha Phansalkar; Judy Edworthy; Elizabeth Hellier; Diane L Seger; Angela Schedlbauer; Anthony J Avery; David W Bates Journal: J Am Med Inform Assoc Date: 2010 Sep-Oct Impact factor: 4.497
Authors: Patrick E Beeler; E John Orav; Diane L Seger; Patricia C Dykes; David W Bates Journal: J Am Med Inform Assoc Date: 2015-10-24 Impact factor: 4.497
Authors: Emily M Campbell; Dean F Sittig; Joan S Ash; Kenneth P Guappone; Richard H Dykstra Journal: J Am Med Inform Assoc Date: 2006-06-23 Impact factor: 4.497
Authors: Yu Ko; Jacob Abarca; Daniel C Malone; Donna C Dare; Doug Geraets; Antoun Houranieh; William N Jones; W Paul Nichol; Gregory P Schepers; Michelle Wilhardt Journal: J Am Med Inform Assoc Date: 2006-10-26 Impact factor: 4.497
Authors: Jamie J Coleman; Heleen van der Sijs; Walter E Haefeli; Sarah P Slight; Sarah E McDowell; Hanna M Seidling; Birgit Eiermann; Jos Aarts; Elske Ammenwerth; Ann Slee; Robin E Ferner; Robin E Ferner; Ann Slee Journal: BMC Med Inform Decis Mak Date: 2013-10-01 Impact factor: 2.796
Authors: Steven Stettner; Sarah Adie; Sarah Hanigan; Michael Thomas; Kristen Pogue; Christopher Zimmerman Journal: Appl Clin Inform Date: 2022-01-05 Impact factor: 2.342
Authors: Justin B Starren; William M Tierney; Marc S Williams; Paul Tang; Charlene Weir; Ross Koppel; Philip Payne; George Hripcsak; Don E Detmer Journal: J Am Med Inform Assoc Date: 2021-04-23 Impact factor: 4.497
Authors: M Kurczewska-Michalak; P Lewek; B Jankowska-Polańska; A Giardini; N Granata; M Maffoni; E Costa; L Midão; P Kardas Journal: Front Pharmacol Date: 2021-11-26 Impact factor: 5.810
Authors: Arthur T M Wasylewicz; Britt W M van de Burgt; Thomas Manten; Marieke Kerskes; Wilma N Compagner; Erik H M Korsten; Toine C G Egberts; Rene J E Grouls Journal: Clin Pharmacol Ther Date: 2022-06-27 Impact factor: 6.903